298 related articles for article (PubMed ID: 15277700)
1. Hyaluronic acid facilitates the recovery of hematopoiesis following 5-fluorouracil administration.
Matrosova VY; Orlovskaya IA; Serobyan N; Khaldoyanidi SK
Stem Cells; 2004; 22(4):544-55. PubMed ID: 15277700
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow connexin-43 expression is critical for hematopoietic regeneration after chemotherapy.
Presley CA; Lee AW; Kastl B; Igbinosa I; Yamada Y; Fishman GI; Gutstein DE; Cancelas JA
Cell Commun Adhes; 2005; 12(5-6):307-17. PubMed ID: 16531325
[TBL] [Abstract][Full Text] [Related]
3. The effects of 5-fluorouracil on hematopoiesis: studies of murine megakaryocyte-CFC, granulocyte-macrophage-CFC, and peripheral blood cell levels.
Yeager AM; Levin J; Levin FC
Exp Hematol; 1983 Nov; 11(10):944-52. PubMed ID: 6662215
[TBL] [Abstract][Full Text] [Related]
4. Modified thrombopoietic response to 5-FU in mice following transplantation of Lin-Sca-1+ bone marrow cells.
Arnold JT; Barber L; Bertoncello I; Williams NT
Exp Hematol; 1995 Feb; 23(2):161-7. PubMed ID: 7828673
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 6 perfusion stimulates reconstitution of the immune and hematopoietic systems after 5-fluorouracil treatment.
Takatsuki F; Okano A; Suzuki C; Miyasaka Y; Hirano T; Kishimoto T; Ejima D; Akiyama Y
Cancer Res; 1990 May; 50(10):2885-90. PubMed ID: 2334892
[TBL] [Abstract][Full Text] [Related]
6. Dock2 participates in bone marrow lympho-hematopoiesis.
Kikuchi T; Kubonishi S; Shibakura M; Namba N; Matsui T; Fukui Y; Tanimoto M; Katayama Y
Biochem Biophys Res Commun; 2008 Feb; 367(1):90-6. PubMed ID: 18157938
[TBL] [Abstract][Full Text] [Related]
7. Protective role of connexin 32 in steady-state hematopoiesis, regeneration state, and leukemogenesis.
Hirabayashi Y; Yoon BI; Tsuboi I; Huo Y; Kodama Y; Kanno J; Ott T; Trosko JE; Inoue T
Exp Biol Med (Maywood); 2007 May; 232(5):700-12. PubMed ID: 17463168
[TBL] [Abstract][Full Text] [Related]
8. Increased mobilization of c-kit+ Sca-1+ Lin- (KSL) cells and colony-forming units in spleen (CFU-S) following de novo formation of a stem cell niche depends on dynamic, but not stable, membranous ossification.
Nagayoshi K; Ohkawa H; Yorozu K; Higuchi M; Higashi S; Kubota N; Fukui H; Imai N; Gojo S; Hata J; Kobayashi Y; Umezawa A
J Cell Physiol; 2006 Jul; 208(1):188-94. PubMed ID: 16575918
[TBL] [Abstract][Full Text] [Related]
9. 5-Fluorouracil effect on cultured murine stem cell progeny and peripheral leukocytes.
Donowitz GR; Quesenberry P
Exp Hematol; 1986 Mar; 14(3):207-14. PubMed ID: 3948930
[TBL] [Abstract][Full Text] [Related]
10. Accelerated recovery of 5-fluorouracil-damaged bone marrow after rosiglitazone treatment.
Djazayeri K; Szilvássy Z; Peitl B; Németh J; Nagy L; Kiss A; Szabó B; Benko I
Eur J Pharmacol; 2005 Oct; 522(1-3):122-9. PubMed ID: 16213483
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human growth hormone promotes hematopoietic reconstitution after syngeneic bone marrow transplantation in mice.
Tian ZG; Woody MA; Sun R; Welniak LA; Raziuddin A; Funakoshi S; Tsarfaty G; Longo DL; Murphy WJ
Stem Cells; 1998; 16(3):193-9. PubMed ID: 9617894
[TBL] [Abstract][Full Text] [Related]
12. Mice severely deficient in growth hormone have normal hematopoiesis.
Sharma Y; Flurkey K; Astle CM; Harrison DE
Exp Hematol; 2005 Jul; 33(7):776-83. PubMed ID: 15963853
[TBL] [Abstract][Full Text] [Related]
13. Age- and irradiation-associated loss of bone marrow hematopoietic function in mice is reversed by recombinant human growth hormone.
Carlo-Stella C; Di Nicola M; Milani R; Longoni P; Milanesi M; Bifulco C; Stucchi C; Guidetti A; Cleris L; Formelli F; Garotta G; Gianni AM
Exp Hematol; 2004 Feb; 32(2):171-8. PubMed ID: 15102478
[TBL] [Abstract][Full Text] [Related]
14. Compensatory mechanisms in platelet production: lack of a paracrine response in W/Wv mice treated with 5-fluorouracil.
Arnold JT; Radley JM; Williams NT
Exp Hematol; 1993 Mar; 21(3):414-9. PubMed ID: 8440339
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of tumor necrosis factor on hematopoiesis seen in vitro are translated to increased numbers of both committed and multipotent progenitors in TNF-deficient mice.
Drutskaya MS; Ortiz M; Liepinsh DJ; Kuprash DV; Nedospasov SA; Keller JR
Exp Hematol; 2005 Nov; 33(11):1348-56. PubMed ID: 16263419
[TBL] [Abstract][Full Text] [Related]
16. Countercurrent centrifugal elutriation (CCE) recovery profiles of hematopoietic stem cells in marrow from normal and 5-FU-treated mice.
Schwartz GN; MacVittie TJ; Monroy RL; Vigneulle RM
Exp Hematol; 1986 Nov; 14(10):963-70. PubMed ID: 3770103
[TBL] [Abstract][Full Text] [Related]
17. Role of stromal-derived factor-1 in the hematopoietic-supporting activity of human mesenchymal stem cells.
Van Overstraeten-Schlögel N; Beguin Y; Gothot A
Eur J Haematol; 2006 Jun; 76(6):488-93. PubMed ID: 16494621
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous knockdown of p18INK4C, p27Kip1 and MAD1 via RNA interference results in the expansion of long-term culture-initiating cells of murine bone marrow cells in vitro.
Wang YY; Yang Y; Chen Q; Yu J; Hou Y; Han L; He J; Jiao D; Yu H
Acta Biochim Biophys Sin (Shanghai); 2008 Aug; 40(8):711-20. PubMed ID: 18685787
[TBL] [Abstract][Full Text] [Related]
19. 5-fluorouracil and mast cell precursors in mice.
Ophir A; Berenshtein E; Ziltener HJ; Razin E
Exp Hematol; 1993 Nov; 21(12):1558-62. PubMed ID: 8405236
[TBL] [Abstract][Full Text] [Related]
20. CD97 is differentially expressed on murine hematopoietic stem-and progenitor-cells.
van Pel M; Hagoort H; Hamann J; Fibbe WE
Haematologica; 2008 Aug; 93(8):1137-44. PubMed ID: 18603564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
